Tanabe Pharma America, Inc.
Clinical trials sponsored by Tanabe Pharma America, Inc., explained in plain language.
-
New pill for sun allergy pain tested in long-term safety trial
Disease control Recruiting nowThis study looks at the long-term safety of an oral medication called dersimelagon for people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) — rare conditions that cause severe pain and skin reactions to sunlight. About 300 participants who completed a …
Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for Hard-to-Treat cancers: experimental drug MT-4561 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called MT-4561 in people with advanced solid tumors (like lung, breast, or pancreatic cancer) who have run out of standard options. The goal is to find a safe dose and see if the drug can shrink tumors. About 27 adults will take part in this …
Phase: PHASE1, PHASE2 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC